GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $16.60 $19.00 Thursday, 18th Apr 2024 ACAD stock ended at $17.07. This is 0.698% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 1.97% from a day low at $17.01 to a day high of $17.35.
90 days $16.60 $29.29
52 weeks $16.60 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2023-10-18 $23.35 $23.54 $23.00 $23.21 1 361 947
2023-10-17 $24.08 $24.60 $23.39 $23.40 1 380 497
2023-10-16 $23.09 $23.81 $22.86 $23.78 1 245 483
2023-10-13 $22.64 $23.14 $22.08 $23.14 1 226 978
2023-10-12 $23.25 $23.25 $22.38 $22.64 1 812 421
2023-10-11 $23.43 $23.71 $23.31 $23.38 1 136 572
2023-10-10 $23.12 $23.80 $22.87 $23.42 2 397 283
2023-10-09 $21.48 $21.91 $21.32 $21.74 886 318
2023-10-06 $21.11 $21.84 $21.03 $21.68 1 082 155
2023-10-05 $21.62 $22.02 $21.48 $21.96 1 073 621
2023-10-04 $20.61 $21.65 $20.60 $21.52 1 512 347
2023-10-03 $21.34 $21.41 $20.66 $20.78 1 318 078
2023-10-02 $20.69 $21.52 $20.31 $21.47 2 237 375
2023-09-29 $21.64 $21.64 $20.54 $20.84 2 752 309
2023-09-28 $25.00 $25.18 $21.16 $21.53 6 978 097
2023-09-27 $23.68 $26.31 $23.19 $25.58 4 761 588
2023-09-26 $23.38 $23.76 $23.20 $23.63 2 811 030
2023-09-25 $23.43 $23.60 $23.08 $23.29 1 502 344
2023-09-22 $23.56 $23.74 $22.99 $23.56 1 662 296
2023-09-21 $23.70 $23.95 $23.27 $23.40 1 594 231
2023-09-20 $24.44 $24.95 $23.76 $23.79 1 273 803
2023-09-19 $24.62 $24.67 $24.05 $24.44 1 825 245
2023-09-18 $24.71 $25.09 $24.18 $24.42 1 890 481
2023-09-15 $25.88 $25.88 $24.67 $24.72 1 766 895
2023-09-14 $25.97 $26.58 $25.62 $25.85 1 272 080
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT